Published in J Neurosurg on May 01, 2001
Radiosurgery for intracranial dural arteriovenous fistulas (DAVFs): a review. Neurosurg Rev (2011) 0.86
Dural arteriovenous fistulas. J Neurosurg (2001) 0.84
Plasma vascular endothelial growth factor and serum soluble angiopoietin receptor sTIE-2 in patients with dural arteriovenous fistulas: a pilot study. Neuroradiology (2005) 0.81
Transarterial Wedged-catheter, Flow-arrest, N-butyl Cyanoacrylate Embolization of Three Dural Arteriovenous Fistulae in a Single Patient. Interv Neuroradiol (2004) 0.78
Regression of a Flow-Related Ophthalmic Artery Aneurysm After Treatment of a Frontal DAVS. A Case Report. Interv Neuroradiol (2005) 0.75
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology (1994) 8.79
Production and auto-induction of transforming growth factor-alpha in human keratinocytes. Nature (1987) 4.19
Influence of patient age and stenosis location on wingspan in-stent restenosis. AJNR Am J Neuroradiol (2007) 3.70
Trefoil peptides: less clandestine in the intestine. Science (1996) 3.60
A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys (1994) 3.29
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest (1997) 2.99
Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology (2000) 2.99
Overexpression of transforming growth factor alpha in psoriatic epidermis. Science (1989) 2.63
Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. Cell (1990) 2.63
Blinded prospective evaluation of sensitivity of MR angiography to known intracranial aneurysms: importance of aneurysm size. AJNR Am J Neuroradiol (1994) 2.59
Stereotactic radiosurgery for arteriovenous malformations of the brain. J Neurosurg (1991) 2.41
Spontaneous spinal cerebrospinal fluid leaks and intracranial hypotension. J Neurosurg (1996) 2.38
Intra-arterial thrombolysis in acute basilar artery thromboembolism: the initial Mayo Clinic experience. Mayo Clin Proc (1997) 2.34
Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPbeta. Nat Med (1997) 2.32
Remote cerebellar hemorrhage after supratentorial surgery. Neurosurgery (2001) 2.30
Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke (2001) 2.30
Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice. J Clin Invest (2000) 2.17
Delayed aneurysm regrowth and recanalization after Guglielmi detachable coil treatment. Case report. J Neurosurg (1998) 2.14
A new type of transforming growth factor-beta, TGF-beta 3. EMBO J (1988) 2.12
Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions. Eur J Vasc Endovasc Surg (2008) 2.10
Regulation of intestinal epithelial cell growth by transforming growth factor type beta. Proc Natl Acad Sci U S A (1989) 2.09
Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Proc Natl Acad Sci U S A (1995) 2.07
Role of conventional angiography in evaluation of patients with carotid artery stenosis demonstrated by Doppler ultrasound in general practice. Stroke (2001) 2.05
Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci U S A (1988) 2.03
Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke (2001) 1.97
Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor. Proc Natl Acad Sci U S A (1999) 1.96
Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol Carcinog (1991) 1.95
Efficacy and current limitations of intravascular stents for intracranial internal carotid, vertebral, and basilar artery aneurysms. J Neurosurg (1999) 1.90
Magnetic resonance imaging-based volume studies in temporal lobe epilepsy: pathological correlations. Ann Neurol (1991) 1.89
Expansion of Pdx1-expressing pancreatic epithelium and islet neogenesis in transgenic mice overexpressing transforming growth factor alpha. Gastroenterology (1999) 1.88
Hepatic processing of transforming growth factor beta in the rat. Uptake, metabolism, and biliary excretion. J Clin Invest (1987) 1.88
Symptomatic pituitary metastases. J Neurosurg (1998) 1.84
Arteriovenous fistulas of the brain and the spinal cord. J Neurosurg (1993) 1.82
Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg (1991) 1.78
Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc Natl Acad Sci U S A (1991) 1.77
A retrospective analysis of pituitary apoplexy. Neurosurgery (1993) 1.76
Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2. Mol Cell Biol (1989) 1.76
Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology (1995) 1.74
Frequency and determinants of postprocedural hemodynamic instability after carotid angioplasty and stenting. Stroke (1999) 1.74
Production of transforming growth factors by human colon cancer lines. Cancer Res (1986) 1.74
A dose-response analysis of arteriovenous malformation obliteration after radiosurgery. Int J Radiat Oncol Biol Phys (1996) 1.70
Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal. J Clin Invest (1989) 1.69
Stents for intracranial aneurysms: the beginning of a new endovascular era? Neurosurgery (1998) 1.69
MRI hippocampal volumes and memory function before and after temporal lobectomy. Neurology (1993) 1.68
Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J Cell Physiol (1987) 1.68
Transforming growth factors and control of neoplastic cell growth. J Cell Biochem (1987) 1.67
Stereotactic gamma knife radiosurgery. Initial North American experience in 207 patients. Arch Neurol (1990) 1.64
Cocaine use and the likelihood of nonfatal myocardial infarction and stroke: data from the Third National Health and Nutrition Examination Survey. Circulation (2001) 1.62
Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model. Cancer Res (1987) 1.61
Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene (2001) 1.59
Prognostic value and determinants of ultraearly angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery (1999) 1.57
Particle image velocimetry assessment of stent design influence on intra-aneurysmal flow. Ann Biomed Eng (2002) 1.56
Gamma knife for glioma: selection factors and survival. Int J Radiat Oncol Biol Phys (1996) 1.56
Stenting and secondary coiling of intracranial internal carotid artery aneurysm: technical case report. Neurosurgery (1998) 1.54
Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part II--Clinical aspects and recommendations. Neurosurgery (2000) 1.54
Reversible drug-induced oxyntic atrophy in rats. Gastroenterology (2000) 1.53
Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation. Mol Cell Biol (1998) 1.52
Venous subarachnoid hemorrhage after inferior petrosal sinus sampling for adrenocorticotropic hormone. AJNR Am J Neuroradiol (1999) 1.52
Intracranial dural arteriovenous fistulae: angiographic predictors of intracranial hemorrhage and clinical outcome in nonsurgical patients. J Neurosurg (1994) 1.51
Childhood dural arteriovenous fistulae of the posterior dural sinuses: three case reports and literature review. Neurosurgery (1995) 1.49
Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery (2001) 1.48
Surgical treatment of spontaneous spinal cerebrospinal fluid leaks. J Neurosurg (1998) 1.48
Remote congenital cerebral arteriovenous fistulae associated with aortic coarctation. Case report. J Neurosurg (1992) 1.47
Superior sagittal sinus laceration complicating an autogenous calvarial bone graft harvest: report of a case. J Oral Maxillofac Surg (1990) 1.46
Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. Proc Natl Acad Sci U S A (1996) 1.46
Treatment of unruptured intracranial aneurysms: a nationwide assessment of effectiveness. AJNR Am J Neuroradiol (2007) 1.44
Stereotactic radiosurgical treatment of cerebral arteriovenous malformations. Gamma Unit Radiosurgery Study Group. Mayo Clin Proc (1995) 1.44
Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc (1998) 1.44
Crk-associated substrate p130(Cas) interacts with nephrocystin and both proteins localize to cell-cell contacts of polarized epithelial cells. Exp Cell Res (2000) 1.42
Angioscopy-assisted aneurysm clipping. Neurosurgery (1999) 1.41
Ventriculoatrial shunt distal catheter placement using transesophageal echocardiography: technical note. Neurosurgery (1992) 1.40
Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family. J Biol Chem (1994) 1.40
Intraarterial recombinant tissue plasminogen activator for ischemic stroke: an accelerating dosing regimen. Neurosurgery (2000) 1.39
Clinical application of region-of-interest techniques to radiologic imaging. Radiographics (1996) 1.39
Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer (1987) 1.37
Retrieval of a Guglielmi detachable coil after unraveling and fracture: case report and experimental results. Neurosurgery (1994) 1.37
"Rhabdoid" meningioma: an aggressive variant. Am J Surg Pathol (1998) 1.37
Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice. Mol Cell Biol (1996) 1.36
Factors predictive of the outcome of frontal lobe epilepsy surgery. Epilepsia (2000) 1.36
A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Gastroenterology (1997) 1.35
Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hum Pathol (1985) 1.34
Emergency carotid endarterectomy for patients with acute carotid occlusion and profound neurological deficits. Ann Surg (1986) 1.34
Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements. FASEB J (2001) 1.33
Clear cell meningioma. A clinicopathologic study of a potentially aggressive variant of meningioma. Am J Surg Pathol (1995) 1.32
Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas. Cancer Res (1992) 1.32
Occlusive hyperemia: a theory for the hemodynamic complications following resection of intracerebral arteriovenous malformations. J Neurosurg (1993) 1.32
Cell surface ectodomain cleavage of human amphiregulin precursor is sensitive to a metalloprotease inhibitor. Release of a predominant N-glycosylated 43-kDa soluble form. J Biol Chem (1998) 1.30
Resective reoperation for failed epilepsy surgery: seizure outcome in 64 patients. Neurology (2004) 1.29
Benign tumors of the foramen magnum. J Neurosurg (1984) 1.28
Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras. Cancer Res (1997) 1.27
Angiographic quantification of contrast medium washout from cerebral aneurysms after stent placement. AJNR Am J Neuroradiol (2002) 1.26
Ineffective secondary prevention in survivors of cardiovascular events in the US population: report from the Third National Health and Nutrition Examination Survey. Arch Intern Med (2001) 1.26
Apical enrichment of human EGF precursor in Madin-Darby canine kidney cells involves preferential basolateral ectodomain cleavage sensitive to a metalloprotease inhibitor. J Cell Biol (1997) 1.25
Temporary balloon protection as an adjunct to endosaccular coiling of wide-necked cerebral aneurysms: technical note. Neurosurgery (1997) 1.24
Saccular aneurysm induction by elastase digestion of the arterial wall: a new animal model. Neurosurgery (1998) 1.24
Ischemic complications of surgery for anterior choroidal artery aneurysms. J Neurosurg (2001) 1.24